Compare · DHR vs MLAB
DHR vs MLAB
Side-by-side comparison of Danaher Corporation (DHR) and Mesa Laboratories Inc. (MLAB): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and MLAB operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $126.04B, about 218.6x MLAB ($576.7M).
- Over the past year, DHR is down 7.3% and MLAB is up 4.0% - MLAB leads by 11.2 points.
- DHR has been more active in the news (18 items in the past 4 weeks vs 4 for MLAB).
- DHR has more recent analyst coverage (25 ratings vs 3 for MLAB).
- Company
- Danaher Corporation
- Mesa Laboratories Inc.
- Price
- $178.15+1.15%
- $104.21-2.36%
- Market cap
- $126.04B
- $576.7M
- 1M return
- +2.34%
- +1.21%
- 1Y return
- -7.25%
- +3.96%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 18
- 4
- Recent ratings
- 25
- 3
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Mesa Laboratories Inc.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The company's Instruments segment designs, manufactures, and markets quality control hardware and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. This segment's products include dialysate meters and calibration solutions, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company's Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Continuous Monitoring segment designs, develops, and markets systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Latest DHR
- Danaher Corporation filed SEC Form 8-K: Other Events
- DZ Bank initiated coverage on Danaher with a new price target
- Wolfe Research resumed coverage on Danaher
- SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
- SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
- Citigroup resumed coverage on Danaher with a new price target
- Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board
- SVP, Human Resources Couchara Georgeann covered exercise/tax liability with 281 shares, decreasing direct ownership by 3% to 8,291 units (SEC Form 4)
- Director Filler Linda was granted 680 shares, increasing direct ownership by 3% to 24,712 units (SEC Form 4)
- Director Stevens Raymond C was granted 680 shares, increasing direct ownership by 5% to 13,728 units (SEC Form 4)
Latest MLAB
- SEC Form S-8 filed by Mesa Laboratories Inc.
- Mesa Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
- Amendment: SEC Form 4 filed by President and CEO Kadia Siddhartha
- Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
- SEC Form 4 filed by President and CEO Kadia Siddhartha
- SEC Form 3 filed by new insider Kadia Siddhartha
- MESA LABS DECLARES QUARTERLY DIVIDEND
- SEC Form 4 filed by Owens Gary M
- Amendment: SEC Form SCHEDULE 13G/A filed by Mesa Laboratories Inc.